Community-acquired pneumonia (CAP) is associated with high rates of morbidity and mortality worldwide; the annual incidence of CAP among adults in Europe has ranged from 1.5 to 1.7 per 1000 population. Intracellular bacteria are common causes of CAP. However, there is considerable variation in the reported incidence between countries and change over time. The intracellular pathogens that are well established as causes of pneumonia are Legionella pneumophila, Mycoplasma pneumoniae, Chlamydophila pneumoniae, Chlamydophila psittaci, and Coxiella burnetii. Since it is known that antibiotic treatment for severe CAP is empiric and includes coverage of typical and atypical pathogens, microbiological diagnosis bears an important relationship to prognosis of pneumonia. Factors such as adequacy of initial antibiotic or early de-escalation of therapy are important variables associated with outcomes, especially in severe cases. Intracellular pathogens sometimes appear to cause more severe disease with respiratory failure and multisystem dysfunction associated with fatal outcomes. The clinical relevance of intracellular pathogens in severe CAP has not been specifically investigated. We review the prevalence, general characteristics, and outcomes of severe CAP cases caused by intracellular pathogens.
Introduction
Community-acquired pneumonia (CAP) is associated with high rates of morbidity and mortality worldwide [1, 2] ; the annual incidence of CAP among adults in Europe has ranged from 1.5 to 1.7 per 1000 population. CAP varies from a mild outpatient illness to a more severe disease requiring hospitalization, and among hospitalized patients, approximately 10 % require admission to an intensive care unit (ICU) [3] .
Intracellular bacteria are common causes of CAP [4, 5] ( Fig. 1 ; Table 1 ). However, there is considerable variation in the reported incidence between countries and change over time. There is limited information on epidemiology of atypical pathogens, sometimes due to lack of standardized diagnostic microbiological testing that can be used routinely. The recent development of molecular microbiological techniques should help to clarify the epidemiology and presentation of intracellular pathogens in CAP and help a shift to more targeted antimicrobial therapy [6] . The intracellular pathogens that are well-established as causes of pneumonia are: Legionella pneumophila, Mycoplasma pneumoniae, Chlamydophila pneumoniae, Chlamydophila psittaci and Coxiella burnetii [7] .
Although extrapulmonary manifestations are often associated with these pathogens in pneumonia, no clinical features allow them to be reliably distinguished from classical bacterial agents of pneumonia such as Streptococcus pneumoniae (pneumococcus) [8] (mainly in patients who need hospitalization). Because these bacteria are naturally resistant to β-lactams, they should be promptly identified. Macrolides and quinolones remain the best empirical treatment of intracellular pathogens owing to their good antimicrobial activity and high intracellular concentrations. Although antibiotic resistance in these intracellular pathogens does not currently represent a clinical problem in the majority of settings, recent studies from Asia and some European countries report the isolation of strains of M. pneumoniae resistant to macrolides, suggesting a need to monitor these pathogens to evaluate the clinical impact of resistance in CAP [9, 10] .
Intracellular pathogens sometimes appear to cause more severe disease with respiratory failure and multisystem dysfunction associated with fatal outcomes. These microorganisms might cause severe CAP in approximately 1-7 % [11] [12] [13] . A retrospective study of 11 patients with ARDS showed that six out of 11 pneumonia cases were caused by C. pneumoniae, and mortality was 100 % in the group of patients with a CURB-65 score of 2 or higher [14] .
The clinical relevance of intracellular pathogens in severe CAP has not been specifically investigated. We review the prevalence, general characteristics, and outcomes of severe CAP cases caused by intracellular pathogens.
Characteristics of intracellular pathogens

Legionella pneumophila
Legionella pneumophila is a gram-negative intracellular bacillus that causes the majority of clinical cases of severe pneumonia (atypical pathogens) termed Legionnaires' disease (LD). Several serotypes have been identified. However, serotype 1 has been associated with 90 % of cases reported in Europe. Legionella spp. are ubiquitous microorganisms in freshwater habitats. Transmission of Legionella spp. is usually by inhalation of aerosols or aspiration of water containing these microorganisms. No evidence of person-to-person transmission exists.
The incubation period is thought to be between 2 and 10 days; however, both longer and shorter incubation periods have been reported.
Mycoplasma pneumoniae
Mycoplasma pneumoniae has a single triple-layered membrane and lacks a cell wall structure; this characteristic makes this microorganism insensitive to β-lactam antibiotics.
Survival of this intracellular pathogen depends on adherence to the respiratory epithelium of the host. Transmission of M. pneumoniae is by respiratory droplets through close contact. The incubation period is long, from 1 to 3 weeks. It also presents prolonged shedding after infection, which allows for a prolonged epidemic.
When an individual has an active infection with M. pneumoniae, it is possible to recover viable bacteria from the nose, throat, trachea, and sputum samples.
Chlamydophila pneumoniae and Chlamydophila psittaci
Chlamydophila pneumoniae is endemic globally and has a unique life cycle, in which this intracellular bacteria expresses different phenotypes that allow it to survive for many years in a phase of rest, which means that it can cause persistent infection. The incubation period is around 21 days; approximately 50 % of young adults and 75 % of elderly persons have serologic evidence of a previous infection. Transmission is by inhaling aerosols containing the microorganism.
Chlamydophila psittaci produces a human pulmonary infection called psittacosis, which can be life-threatening. For this reason, C. psittaci is classified as a Centers for Disease Control and Prevention (CDC) biothreat agent. Transmission is by inhaling aerosols containing the microorganism, especially where humans come into close contact with infected birds.
Coxiella burnetii
Coxiella burnetii is an obligate intracellular gram-negative bacterium. It is the causative agent of the human disease Q fever. This microorganism replicates to high numbers within a specific vacuole, thriving within a low pH, highly proteolytic, and oxidative environment. Infection of humans is through the inhalation of contaminated aerosols.
Epidemiology
Intracellular pathogens are considered to be a common cause of CAP and have been involved in approximately 20-30 % of cases. These microorganisms may cause severe CAP in approximately 1-7 % [11] [12] [13] .
Legionella pneumophila
Legionella is responsible for summer to autumn outbreaks and is an important cause of CAP and hospitalacquired pneumonia [6, 15] .
In Europe and the USA, L. pneumophila serogroup 1 causes the vast majority of Legionella pneumonia, accounting for approximately 85 % of cases [16] . However, L. longbeachae is the species reported in approximately 25 % of the pneumonia cases in countries such as Australia, Scotland, Thailand, and New Zealand [17] [18] [19] .
LD is rare in children; the majority of reported cases occur in people aged 50 years or over, and cases predominantly present in male patients [20] (Fig. 2) . The epidemiology of LD is well recorded because it is a notifiable disease. In 2014, a total of 6941 cases of LD were reported by 28 EU Member States and Norway [21] . Five countries (France, Italy, Spain, Germany, and Portugal) accounted for 74 % of all notified cases (Fig. 3) . Most cases were community-acquired (74 %), 18 % were travel-associated, and 7 % were linked to healthcare facilities. People over 50 years of age accounted for 80 % of all cases. The [12] . Nevertheless, the recent article by Jain et al. [11] from the USA concerning the etiology of pneumonia in the community (EPIC) study reported that L. pneumophila was present in 1 % of ICU patients with a defined microbial etiology. In the USA, the CDC estimates that between 8000 and 18,000 people are hospitalized with LD each year and approximately 5-30 % of these patients die [23] . Welte et al. [24] , in a review article which included 46 CAP studies from 13 European countries, reported a frequency of Legionella spp. of 12 % in ICU CAP cases. Today, with improved detection methods, including the urinary antigen test, more cases are being identified and many more mild cases than in the past are being recognized.
In patients with risk factors (smoking, chronic cardiovascular or respiratory disease, diabetes, alcohol abuse, and immunosuppression), LD is sometimes complicated by more severe disease (cavitation and pleural effusions) [25] [26] [27] . Jacobson et al. [28] , in a study of Legionella pneumonia in cancer patients, reported the presence of multilobar pneumonia in 82 % of the patients, bilateral involvement in 80 %, and pleural effusion in 56 % of the patients.
Mycoplasma pneumoniae
Mycoplasma pneumoniae is a common cause of CAP in adults [12, 16, 29] . The incidence of M. pneumoniae CAP is lower in elderly patients compared with young adults [30] . The study by Dumke et al. [6] showed that M. pneumoniae was more common in younger patients and more frequent in females and in patients with fewer comorbid conditions than CAP from other causes. In CAP, M. pneumoniae accounts for up to 37 % of the patients treated as outpatients and 10 % of patients that required hospitalization [31, 32] . The study by Cilloniz et al. [12] reported a rate 2.5 % for mixed infection with M. pneumoniae and S. pneumoniae in CAP patients with defined microbial etiology. In a few cases, pneumonia caused by M. pneumoniae developed into refractory or severe pneumonia [33, 34] . Miyashita et al. [33] , in a study of severe M. pneumoniae infections in ICU patients, found that 6 % of the 227 patients with Mycoplasma infection were admitted to the ICU because of acute respiratory failure. In a review of 52 cases of fulminant M. pneumoniae pneumonia from Japan, those authors observed that the dominant populations with fulminant M. pneumoniae pneumonia were young adults without severe underlying diseases. The major clinical manifestation was respiratory failure with diffuse abnormal findings in radiological examinations. A diffuse interstitial pattern was observed 61.5 %. A diffuse alveolar pattern with or without air bronchogram was observed in 25.0 %. A mixed interstitial and alveolar pattern was observed in 13.5 % [34] . More severe cases of Mycoplasma pneumonia had been reported among refugees (Welte T. ISICEM 2016, Brussel). The poorly effective adaptive immune response among these patients should be recognized in the future. Recent reports from Asia and some European countries describe the isolation of strains of M. pneumoniae resistant to macrolides [9, 10] .
Chlamydophila pneumoniae and Chlamydophila psittaci
Up to 20 % of CAP in adults is reported to be caused by C. pneumoniae [12, 35] . The majority of these data are based on serology, and the relationship between positive C. pneumoniae serology and CAP etiology is the subject of debate. Cillóniz et al. [12] found that CAP was caused by C. pneumoniae in only 3 % of the cases. Chalmers et al. [36] found a maximum of 2.2 % of CAP caused by C. pneumoniae. The study by Arnold et al. [16] showed that the incidence of CAP due C. pneumoniae from 4337 patients was 8 % in North America, 7 % in Europe, 6 % in Latin America, and 5 % in Asia. Lui et al. [37] , in a prospective observational study of hospitalized patients with CAP, reported that 29 % of cases with defined etiology were caused by intracellular pathogens; of these, 35 % were classified as PSI IV-V, 5 % of these cases needed ICU admission, and the mortality rate was 2.2 % in the atypical group. A study from Thailand on severe CAP reported that the incidence of C. pneumoniae pneumonias was 3-23 cases per 100,000 population; the highest rates were among patients aged under 1 year (18-166 cases per 100,000) and those aged 70 years or over cases per 100,000) [38] .
Several cases of severe pneumonia have been reported in Europe in the last 10 years [39] [40] [41] . A French study of distinctive features between C. psittaci and L. pneumophila pneumonia in patients admitted to the ICU showed that severe psittacosis shares many features with severe legionellosis, including extrapulmonary manifestations, biological features, and outcome [42] .
The mortality rate associated with C. pneumoniae infection is low. However, if the first upper respiratory signs associated with C. pneumoniae infection are not treated, severe disease or even death may result [43] . Diagnosis of psittacosis can be difficult, and many more cases may occur that are not correctly diagnosed or reported.
Coxiella burnetii
European countries such as the UK [44, 45] , France, Greece, Spain, and the Netherlands [46, 47] have reported large outbreaks. In the USA, surveillance studies from 2000 to 2012 reported an incidence of 0.38 cases per million persons/year, with a mortality rate of 2 % and a hospitalization rate of 62 % [48] .
A German study, published in 2014, reported a high prevalence of Q fever as the cause of CAP (3.5 %) in the summer of 2005 in Germany [49] . In 2007, a major epidemic occurred in the Netherlands which resulted in approximately 2300 reported cases. An epidemiologic explanation for this outbreak was the possible spatial link between dairy goat farms and human cases [50] . Wielders et al. [51] described the epidemiological and clinical features of 183 hospitalized acute Q fever patients. Pneumonia was present in 86 % of patients, of which 4 % were admitted to the ICU; the mortality rate was 6 %.
It has been reported that Q fever is most frequent in men. In Australia and France, men are five times and 2.5 times more likely than women to develop the disease, respectively [52] .
Co-infection with other pathogens
The study by Cillóniz et al. [53] , which included 362 adult patients with CAP admitted to the ICU, found that 10 % of CAP cases with defined microbial etiology were caused by intracellular pathogens. Co-infection involving intracellular pathogens and other microorganisms were observed in 30 % of cases caused by intracellular pathogens.
Pathogenesis
One of the principal characteristics of intracellular pathogens is that they are able to grow and reproduce inside the cells of their host. This characteristic helps these pathogens to evade the host immune system. Antimicrobial treatment for these pathogens is very challenging because many antimicrobials are unable to access intracellular spaces and reach optimum therapeutic concentrations within the infected cells.
Legionella pneumophila
Legionella pneumophila grows in lung macrophages after aerosols are inhaled from contaminated water sources. A recent published letter reported a probable personto-person transmission of LD; the authors described two cases of LD. The patients were relatives (mother and son), and the factors that suggested person-to-person transmission were the severity of the respiratory symptoms, 8 h of close contact between the two patients, and the small area of the non-ventilated room where the contact took place [54] .
Legionella pneumophila multiplies within the cell until the cell ruptures and then infects other macrophages. L. pneumophila has virulence factors that potentiate the infection of macrophages and inhibit phagosomal fusion, thus avoiding macrophage cell death pathways and promoting bacterial survival, which allows sufficient time for replication. When L. pneumophila establishes infection, this intracellular bacterium causes a fibrino-purulent pneumonia (deposition of fibrin clots and fibrin membranes in the alveolar space). Hepatic involvement is commonly manifested by mildly increased serum transaminases in Legionella CAP.
Mycoplasma pneumoniae
This microorganism is transmitted by aerosol from person to person. In general, the incubation period varies from 1 to 3 weeks. Approximately 3-4 % of patients with M. pneumoniae pneumonia develop severe CAP associated with respiratory failure and acute respiratory distress syndrome (ARDS). The study by Nilsson et al. [55] showed that the severity of M. pneumoniae seems to depend on the M. pneumoniae bacterial load rather than the M pneumoniae genotype (MP1 or MP2). Other studies associated severity of CAP with the delayed administration of adequate antimicrobials in severe M. pneumoniae pneumonia [33, 34] .
Pathogenicity of M. pneumoniae depends on its attachment to the respiratory epithelium and initiation of injury to the host. The study by Jiang et al. [56] showed the association between abnormalities in ciliated respiratory epithelium in children and severity of M. pneumoniae infection. However, this study did not examine the origin of these abnormalities in ciliated respiratory epithelium.
The principal virulence factors in M. pneumoniae are related to hydrogen peroxide production, lipoproteins, and more recently reported CARDS toxin (ADP-ribosylating and vacuolating cytotoxin) [57] that exhibits similarities with pertussis toxin.
In addition to these virulence factors, the emergence of macrolide-resistant M. pneumoniae strains [58] [59] [60] (by point mutations in the 23S RNA gene [61] ) and the frequency of extrapulmonary complications (neurological, cardiac, dermatological, musculoskeletal, and hematological) reportedly make treatment more difficult [62] . Extrapulmonary complications are associated with an active immune response to the pathogen and excessive expression of cytokines such as IL-18, which was demonstrated in the case-control study of pneumonia caused by M. pneumoniae reported by Tanaka et al. [63] .
Chlamydophila pneumoniae
Chlamydophila pneumoniae has a specific tropism and exhibits cytotoxic activity towards the airway epithelium, in which it proliferates and destroys infected cells by lysis.
Co-infection with other respiratory pathogens may play an important role in approximately 30 % of adult patients with CAP [64] .
Chlamydophila pneumoniae need neutrophil granulocytes cells to live and multiply; however, these kinds of cells have a short life. The inhibition of neutrophil apoptosis by C. pneumoniae appears to play a major role in the production of infection of these cells by C. pneumoniae [65] .
Coxiella burnetii
The principal reservoirs of infection are farm and domestic animals, especially sheep and goats. Infection of humans is mainly through inhaling contaminated aerosols, which occurs mainly during and several weeks after labor and delivery in goats and sheep. This bacterium is resistant in the environment and it may survive for long periods of time in dust and fecal particles. The incubation period varies from 7 to 40 days with an average of 21 days [66, 67] .
The target cells for C. burnetii infection are monocytes and macrophages. C. burnetii lives inside phagosomes with special acid characteristics that allow this pathogen to receive nutrients and to resist antibiotics [68] . It is known that lipopolysaccharide (LPS) is the main virulence factor of C. burnetii infection. Development of infection is related to host comorbidities and cell-mediated immunity.
Clinical presentation
Legionella pneumophila
Pneumonia caused by L. pneumophila is indistinguishable by clinical and radiographic features from other pneumonias caused by "typical" pathogens such as pneumococcus. The principal risk factors for LD are current smoking (which compromises mucociliary clearance), current alcohol abuse, diabetes, chronic obstructive disease, and immunosuppression.
LD can present as a severe pneumonia that may be accompanied by systemic symptoms such as fever, diarrhea, myalgia, impaired renal and liver functions, and delirium. LD is also frequently associated with hyponatremia, dry cough, elevated lactate dehydrogenase, and markedly elevated C-reactive protein levels and platelet count. Although none of these features are specific for LD, Haubitz et al. clearly demonstrated that in the absence of at least two of these factors, LD was excluded with 99 % accuracy [69] .
Mycoplasma pneumoniae
Mycoplasma pneumoniae is often associated with mild to moderate pneumonia [70] . Pneumonia caused by M. pneumoniae presents with frequent extrapulmonary manifestations (encephalitis, optic neuritis, acute psychosis, stroke, cranial nerve palsies, and aseptic meningitis) [61, 71] . The clinical relevance of macrolide resistance of M. pneumoniae in CAP cases is still under debate, but some studies suggest that severity of the disease and clinical manifestations in adults with resistant strains are similar to disease severity in patients with susceptible strains who are receiving treatment [59, 72] . Nevertheless, several studies found that cases with macrolide-resistant M. pneumoniae presented with more persistent signs and symptoms; a significantly longer duration of antibiotic therapy and longer time of resolution of fever were also observed [60, 73] . More studies are needed to understand the clinical significance of macrolide-resistance M. pneumoniae in adults with CAP.
Chlamydophila pneumoniae and Chlamydophila psittaci
The clinical course of infection with C. pneumoniae may vary from subclinical to mild and, more rarely, severe pneumonia. The outcome of the patients is directly related to immune competence. Risks for infection and persistence are advanced age, current smoking, male gender, glucocorticoid use, and residence in a long-term care facility.
Respiratory infections caused by C. pneumoniae are often asymptomatic, but approximately 10 % of adolescent and young adults develop a mild disease [74] . Sore throat with hoarseness is often severe and may precede pneumonia by up to a week and resolve before pneumonia onset, resulting in a biphasic illness.
Common symptoms of C. psittaci infection include abrupt onset of fever, chills, headache, myalgia, nonproductive coughing, and dyspnea. Radiographic findings may include lobar or interstitial infiltrates. In some cases there are complications such as pericarditis, endocarditis or myocarditis, hepatomegaly, and splenomegaly [43] . Persons exposed to infected birds are at risk of infection with C. psittaci, and this disease is found worldwide, with approximately 70 % of the cases having a known source of infection as a result of exposure to pet birds [75] .
Coxiella burnetii
Pneumonia caused by C. burnetii is generally mild but progression to ARDS can occur [8] . Fever and headache are the most frequent symptoms in patients with Q fever pneumonia [76] . Also extrapulmonary complications (hemophagocytosis, lymphadenopathy mimicking lymphoma, splenic rupture, neurological manifestations, pericarditis, myocarditis) were described in cases of Q fever pneumonia [76] .
Microbiological diagnosis
Intracellular pathogens are difficult to culture and isolate. The general microbiological assays to diagnose these pathogens are serology, antigen detection, and molecular assays such as PCR. Microbiological diagnosis is generally recommended in hospitalized patients because adequacy of the initial antibiotic treatment is a key factor for the prognosis of pneumonia. Furthermore, in patients with severe pneumonia, broad-spectrum antibiotic therapies that cover typical and atypical pathogens are recommended, and rapid diagnoses help the optimal antibiotic therapy, prompt de-escalation, and stewardship. Since a great percentage of severe cases are managed with mechanical ventilation, bronchoalveolar lavage (BAL) and bronchoalveolar aspirates (TBAS) are the principal respiratory samples for the diagnosis of these pathogens (Fig. 4) .
Culture
Culture of M. pneumoniae is the reference diagnostic test for this pathogen but is rarely performed. The principal limitation is that it is expensive and time-consuming (almost 10 days), requires specialized media, technical expertise, and is not available except in reference laboratories. The sensitivity is 60 % and specificity is 100 %.
Culture of respiratory samples (TBAS or BAL) in buffered charcoal yeast extract agar (BCYE) is the gold standard for diagnosis of L. pneumophila. Isolation of the strains involved in the infection allows epidemiological typing, which provides valuable data for the control and prevention of further cases. Sensitivity of Legionella culture varies widely, ranging from 50 to 80 % [77, 78] . In cases of severe CAP, the sensitivity is higher because of the higher microbial load in respiratory samples.
Coxiella burnetii is a pathogen with high infectivity, making it dangerous and difficult to isolate. Culture of this pathogen is performed on human erythroleukemia cells (HEL cells) over 5-7 days, or it is possible to observe C. burnetii by microscopy after immunofluorescent staining [79] .
Antigen detection
Diagnosis of L. pneumophila is made most frequently through detection of Legionella antigen in urine (urinary antigen test); the sensitivity of this test is approximately 70 % with specificity of 95 % [80] . The principal problem with this assay is that it is only diagnostic for L. pneumophila serogroup 1, which is the most frequent serogroup involved in CAP cases. The antigen of Legionella can persist in urine for weeks and months following infection.
Also the direct immunofluorescence assay in sputum samples, respiratory secretions, or pleural fluid is an easy way to diagnose Legionella, with a sensitivity ranging from 33 to 68 % and a specificity of 95 %, but the principal obstacle is to collect a good quality sample.
Serology
Serology is the main diagnostic assay for M. pneumoniae, C. pneumoniae, C. psittaci, and C. burnetii. However, the lack of specificity because of possible cross-reactivity with other microorganisms is a major limitation. Also, IgM and IgG may take 6-8 weeks to appear, requiring collection of both acute and convalescent titers.
Acutely elevated IgM titers for M. pneumoniae or C. pneumoniae in a patient with severe CAP will be considered diagnostic but are limited by their moderate sensitivity and specificity. A fourfold increase in IgG titer is indicative of past exposure to infection by M. pneumoniae or C. pneumoniae.
In the case of C. burnetii, persistently elevated IgG levels indicate chronic Q fever rather than acute infection.
Molecular diagnosis (PCR)
Molecular techniques such as PCR or multiplex PCR are of use for identification of intracellular pathogens (M. pneumoniae [81, 82] , C. pneumoniae, C. psittaci, C. burnetii) in CAP. These new techniques can also help to identify the infectious strains of these problematic pathogens.
Although serology is the main diagnostic test for C. pneumoniae and C. psittaci, this is not well standardized, and PCR is emerging as a rapid sensitive mode of detection [83] . PCR in blood samples or serum provides a rapid and definitive diagnosis of C. pneumoniae. Culture of infected tissue is also an option but it requires special facilities. PCR in sputum samples has greater sensitivity (80 %) and specificity (90 %) for the detection of Legionella and can also potentially detect other species such as L. longbeachae [84] .
Molecular assays will help in the early diagnosis of chronic and acute Q fever [85] . In recent years, several molecular assays have been developed to detect the DNA of C. burnetii in clinical samples and in cell culture.
Antibiotic treatment
The selection of empiric antibiotic treatment of CAP is generally based on possible risk factors for specific pathogens and the knowledge of local antimicrobial resistance. Therefore, in severe cases it is recommended that empiric antibiotic treatment should cover typical and atypical (intracellular) pathogens as a result of the difficulty of discriminating between typical and atypical pneumonia ( Table 2) .
Legionella pneumophila
Antibiotics such as macrolides, tetracyclines, and quinolones are effective again this intracellular pathogen [86] [87] [88] . The in vitro activity of azithromycin and fluoroquinolones is similar but superior to older macrolides [86, 87, 89] . British Thoracic Society (BTS) guidelines recommend fluoroquinolones for severe LD [30] . The addition of rifampicin is advised for immunocompromised patients or patients with severe pneumonia. Duration of the treatment is 8-14 days for non-severe LD. Antibiotic therapy should be continued for 10-21 days in immunocompetent patients to decrease the rate of relapse [90] .
Mycoplasma pneumoniae
Antimicrobial therapy with tetracyclines, macrolides, or fluoroquinolones shortens the duration of clinical symptoms [90] . Macrolides and tetracyclines are bacteriostatic against M. pneumoniae, whereas fluoroquinolones possess bactericidal activity [91, 92] .
Azithromycin is recommended for 5 days while other macrolides such as clarithromycin and erythromycin, as well as tetracyclines and fluoroquinolones, usually require longer courses.
Corticosteroids may be beneficial in severe M. pneumoniae pneumonia [93] [94] [95] , but experience with this therapy is limited to case reports and small series. The recent study by Miyashita et al. [93] , which included 41 patients with refractory or severe M. pneumoniae pneumonia, observed that the administration of steroids to patients with refractory and severe pneumonia resulted in the rapid improvement of symptoms and a decrease in serum LDH levels in all patients.
Chlamydophila pneumoniae and Chlamydophila psittaci
Antibiotic treatment for C. pneumoniae is very similar to M. pneumoniae. Therapy for 2 weeks with a macrolide, tetracycline, doxycycline, or fluoroquinolone is recommended [90] . Azithromycin and clarithromycin are an alternative option to erythromycin because of improved intestinal tolerance. In case of patients with intolerance to macrolides or tetracyclines, fluoroquinolones such as levofloxacin or moxifloxacin are good alternatives.
Coxiella burnetii
Doxycycline is the treatment of choice for acute Q fever, and 2 weeks of therapy is recommended for adults [8] . Doxycycline has been shown to result in a mean time to defervescence of 2-3 days after the start of therapy [96] . Levofloxacin or a macrolide is an alternative therapy.
The current recommendations from the CDC are to treat pregnant women with acute Q fever with co-trimoxazole up until the final 6 weeks of pregnancy, and to give doxycycline and hydroxychloroquine postpartum for 12 months to women who develop a serologic profile of chronic Q fever (phase 1 IgG titer ≥1:1024) [97, 98] . Because there is a risk to the fetus, doxycycline is contraindicated during pregnancy. 
Research opportunities
Although intracellular pathogens in severe CAP requiring ICU treatment are involved in a few percent of cases [12, 13, 99] , the importance of these pathogens is due to the frequent complications and the high rate of mortality among these populations [14, 34] . Microbiological diagnosis is an important point to take into consideration, as the information will determine whether or not double coverage can be stopped, or determine the duration of therapy also in order to avoid the overuse of antibiotics-the principal risk factors for developing resistance, especially macrolide resistance, in M. pneumoniae [59] . Today, one question needs to be answered: what is the best microbiological technique for diagnosing these pathogens and what is the optimum sample in severe CAP? In general, serology and culture cannot assist patient care because of their retrospective or slow results. The test of choice is PCR owing to its high sensitivity and specificity reported in several studies [100] [101] [102] . However, the impact of these new platforms on clinical outcomes and their cost-effectiveness have not been investigated. Acute M. pneumoniae infection in severe cases will be diagnosed with single-titer IgM assays, which provide quicker results but are limited by their moderate sensitivity and specificity. Recent studies reported high sensitivity for PCR assays, which can be applied to a range of respiratory specimens, including sputum and BAL. However, the methods have not been standardized. Similar issues exist for serological and molecular diagnosis of C. pneumoniae. On the other hand, diagnosis of L. pneumophila is standardized and described in current international guidelines for CAP [30, 103] . The urinary antigen test is the best way to diagnose this pathogen. With a sensitivity of between 65 and 100 % and sensitivity of 94 %, this assay detects infection by serogroup 1, which is responsible for 90 % of Legionella cases in Europe. Recent data suggest that PCR of lower respiratory specimens, including BAL and BAS, makes it possible to diagnose early, low bacterial load and non-serogroup 1 infections [99, 104] . Combining PCR with urine tests may maximize the diagnostic yield. 
